Ernexa Therapeutics Inc. Accounts Payable, Trade, Current
Ernexa Therapeutics Inc. (ERNA) had Accounts Payable, Trade, Current of $176.00 thousand as of 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableTradeCurrent · last filed 2015-11-09
- 2015-09-30: Accounts Payable, Trade, Current $176.00K.
- 2015-06-30: Accounts Payable, Trade, Current $120.00K.
- 2014-12-31: Accounts Payable, Trade, Current $423.00K.
| Period end | Accounts Payable, Trade, Current |
|---|---|
| 2015-09-30 | $176.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $120.00K 10-Q · filed 2015-08-10 |
| 2014-12-31 | $423.00K 10-Q · filed 2015-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |